Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

59.3K
Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
59.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distal Agrin (AGRN) Congenital Myasthenic Syndrome With Mitochondrial Dysfunction.

European journal of neurology·2026
Same author

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Statins in Genetic Myopathies: A Retrospective Analysis of Safety and Tolerability.

Neurology. Clinical practice·2026
Same author

Congenital myasthenic syndrome: is it time for a name change to genetic myasthenic syndrome?

Brain : a journal of neurology·2026
Same author

Immune-Driven Expression in Inclusion Body Myositis With T-Cell Large Granular Lymphocytic Leukemia.

Annals of clinical and translational neurology·2026
Same author

Expanding the Molecular and Pathologic Spectrum of <i>HSPB8</i> Myopathy and Distal Motor Neuropathy.

Neurology. Genetics·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

636

A Pattern Recognition Approach to Myopathy.

Margherita Milone

    Continuum (Minneapolis, Minn.)
    |October 2, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Diagnosing muscle diseases requires integrating clinical findings with genetic tests and muscle biopsies. Accurate diagnosis of these heterogeneous conditions is crucial for effective treatment and improved patient outcomes.

    More Related Videos

    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
    08:16

    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

    Published on: March 4, 2014

    33.0K
    Semi-automated Analysis of Mouse Skeletal Muscle Morphology and Fiber-type Composition
    08:36

    Semi-automated Analysis of Mouse Skeletal Muscle Morphology and Fiber-type Composition

    Published on: August 31, 2017

    11.0K

    Related Experiment Videos

    Last Updated: Jan 6, 2026

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    636
    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
    08:16

    Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

    Published on: March 4, 2014

    33.0K
    Semi-automated Analysis of Mouse Skeletal Muscle Morphology and Fiber-type Composition
    08:36

    Semi-automated Analysis of Mouse Skeletal Muscle Morphology and Fiber-type Composition

    Published on: August 31, 2017

    11.0K

    Area of Science:

    • Neurology
    • Genetics
    • Pathology

    Background:

    • The spectrum of inherited and acquired muscle diseases is expanding due to advances in genetic testing and biomarker development.
    • Muscle diseases can be isolated or part of multisystem disorders, presenting diagnostic challenges, especially when symptoms mimic other conditions like peripheral neuropathy.
    • The development of targeted therapies for specific genetic variants and immune-mediated muscle diseases highlights the need for precise diagnoses.

    Purpose of the Study:

    • To review the clinical elements, muscle involvement patterns, and diagnostic tools for diagnosing muscle diseases.
    • To emphasize the heterogeneity and diagnostic challenges associated with muscle diseases.
    • To underscore the importance of accurate diagnosis for patient care and prognosis.

    Main Methods:

    • Review of clinical assessment strategies.
    • Integration of clinical and laboratory findings.
    • Discussion of diagnostic tools including genetic testing and muscle biopsy.
    • Consideration of artificial intelligence in diagnostics.

    Main Results:

    • Clinical assessment and integrated findings are central to diagnosing and treating muscle diseases.
    • Genetic testing is increasingly used for genetic myopathies, while muscle biopsy remains vital for acquired diseases and variant pathogenicity assessment.
    • Accurate diagnosis significantly impacts patient care, prognosis, and access to targeted therapies.

    Conclusions:

    • Accurate diagnosis of specific muscle diseases is paramount for effective patient management and prognosis.
    • A rigorous characterization of patient phenotype correlated with genetic findings is essential.
    • Continued advancements, including AI, are optimizing the diagnostic process for muscle diseases.